Overview


According to FutureWise analysis the market for 3D printed drugs in 2023 is US$ 0.33 billion, and is expected to reach US$ 0.67 billion by 2031 at a CAGR of 9.42%.

3D printing, or additive manufacturing, creates 3D objects by layering them one by one, referring to a digital model. This technique has the potential to revolutionize various industries and is becoming increasingly popular among businesses worldwide. It helps in the production of personalized 3D objects with complex shapes and details. It is a form of manufacturing that helps in producing complex and customized objects with intricate shapes and details. 3D printed drugs refer to pharmaceuticals that are manufactured using 3D printing technology. Traditional methods of drug production involve mass manufacturing of medications using presses or mold. However, with advancements in 3D printing, it has become possible to create personalized and customizable drug formulations.

The process of 3D printing entails the production of medication using a computer-guided printer that deposits pharmaceutical substances in controlled quantities layer by layer with precision. This technology allows for the production of complex drug structures with specific dosages, release rates, and even multiple active ingredients in a single pill. The process can be tailored to an individual patient's needs, forming personalized medicine. 3D printing helps in the creation of complex drug structures and offers potential benefits such as improved patient compliance, convenience, and the ability to address specific medical requirements.

FutureWise Market Research has published a report that provides an insightful analysis of 3D printed drugs market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that 3D printed drugs market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Aprecia Pharmaceuticals LLC
  • GlaxoSmithKline Plc
  • FabRx Ltd
  • Hewlett Packard Caribe
  • Merck KGaA
  • Cycle Pharmaceuticals
  • Tvasta
  • AstraZeneca
  • Salter Labs
  • Terumo Corporation

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in the 3D Drug Eluting Balloons Applications in Healthcare Market:

  • In April 2021,  Nanoform Finland Plc, a company that specializes in developing innovative nanoparticle medicine, is collaborating with Aprecia, a 3DP (three-dimensional printing) pharmaceutical company, to explore the potential synergies between their technologies in developing nanoparticle-enabled 3DP dosage forms. The aim of this partnership is to provide patients and the pharmaceutical industry with new and improved patient-centered therapies.

The global 3D printed drugs market is evaluated to witness a significant expansion during the projected period, and this is primarily due to the rising demand for personalized medications, the rising cases of chronic illnesses, and various other diseases. Patients now demand customized treatment as it involves more targeted treatment with very few side effects, and by using 3D printed drugs, it is possible to customize medication by keeping the patient's medical history in mind. Through this process, medical professionals can know whether the patient needs therapeutic combinations to treat diseases, and also it helps in speedy recovery. Additionally, as technology involves, there are more chances of people being aware of 3D printing drugs and using them for their benefit. Furthermore, there are new market participants entering this market with innovative technology to capture the market. For example, FabRX provides personalized medications and drug-filled medical devices, which drives the target market growth. However, there are some limiting factors, including data breaches. Patience nowadays can't trust the medical professional because this technique requires the patient's medical history and other significant details about them, which are generally kept online or on the cloud by the professionals; these sensitive data can be hacked easily, creating problems for the patients as well as the medical professionals and hence acts as a restraining factor on the market growth.

By Technology

  • Inkjet printing
  • Fused deposition modeling
  • Stereolithography
  • Others

By Application

  • Orthopedic
  • Neurology
  • Hearing and Audibility Aid
  • Medical Implants
  • Dental
  • Others

By Drug Form

  • Tablet
  • Capsules
  • Multi-Drug Implants
  • Nanoparticles
  • Solutions
  • Nano Suspension
  • Encapsulated within a polymer
  • Implant

By Type

  • Spritam
  • Others

By End-Users

  • Hospitals
  • Clinics
  • Research Laboratories

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America accounts for the largest share of the 3D printed drugs market and is expected to continue this dominance in the forecast period. The growing cases of chronic diseases, particularly affecting the geriatric population, are the key factor influencing the need for 3D printed drugs in the United States. Alongside, the United States and Canada have a strong healthcare infrastructure which is also a factor driving the growth of the target market. The growing investments by the market participants and increasing healthcare expenditures by both public and private bodies increases the innovation and lead to technological breakthroughs, further influencing the market growth. Hence, considering the abovementioned factors, North America is evaluated to dominate the 3D printed drugs market in the projected timeframe.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the 3D Printed Drugs Market By Technology, By Application, By Drug Form, By Type, By End-Users and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   3D Printed Drugs Market Variables, Trends and Scope

    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of 3D Printed Drugs Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   3D Printed Drugs Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   3D Printed Drugs Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Inkjet printing
        2. Fused deposition modeling
        3. Stereolithography
        4. Others

  • 8.   3D Printed Drugs Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Orthopedic
        2. Neurology
        3. Hearing and Audibility Aid
        4. Medical Implants
        5. Dental
        6. Others

  • 9.   3D Printed Drugs Market, By Drug Form Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Tablet
        2. Capsules
        3. Multi-Drug Implants
        4. Nanoparticles
        5. Solutions
        6. Nano Suspension
        7. Encapsulated within a polymer
        8. Implant

  • 10.   3D Printed Drugs Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Spritam
        2. Others

  • 11.   3D Printed Drugs Market, By End-Users Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Hospitals
        2. Clinics
        3. Research Laboratories

  • 12.   North America 3D Printed Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 13.   Latin America 3D Printed Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 14.   Europe 3D Printed Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 15.   Asia Pacific 3D Printed Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 16.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 17.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 18.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Aprecia Pharmaceuticals LLC
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. GlaxoSmithKline Plc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. FabRx Ltd
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Hewlett Packard Caribe
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Merck KGaA
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Cycle Pharmaceuticals
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Tvasta
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. AstraZeneca
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Salter Labs
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Terumo Corporation
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 19.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 20.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11